K-Lyte/Cl and Ranibizumab
Determining the interaction of K-Lyte/Cl and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: potassium bicarbonate / potassium chloride
Brand name: Effervescent Potassium/Chloride, K-Lyte/Cl, Effervescent Potassium, K-Effervescent, K-vescent, K-vescent, K+Care ET, Klor-Con/EF, Effer-K, Klorvess Effervescent, K-Lyte/Cl 50
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- K-Lyte/Cl-Ranibizumab Intraocular
- K-Lyte/Cl-Ranibizumab ophthalmic
- K-Lyte/Cl-Ranitidine
- K-Lyte/Cl-Ranitidine Capsule
- K-Lyte/Cl-Ranitidine Hydrochloride
- K-Lyte/Cl-Ranitidine Injection
- Ranibizumab-K-Phos M.F.
- Ranibizumab-K-Phos Neutral
- Ranibizumab-K-Phos No. 2
- Ranibizumab-K-Phos Original
- Ranibizumab-K-Prime
- Ranibizumab-K-Sol